Skip to main content
OpenTrials

Clinical trial condition

HIV Infections

Explore clinical trials studying HIV Infections. Study availability and eligibility vary by location and protocol.

3,323 public trials 107 recruiting studies
Refine in advanced search Browse all conditions

HIV Infections trial results

Recruiting

Implementation Study of Lenacapavir Pre-exposure Prophylaxis for HIV Prevention

NCT07473778

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • UAB 1917 Research Clinic Birmingham, Alabama, United States
  • Pacific Oaks Medical Group Beverly Hills, California, United States
  • Ruane Clinical Research Group Inc. Los Angeles, California, United States
  • Family Health Centers of San Diego San Diego, California, United States
View all 34 locations
View Trial Details
Recruiting

Positive Peers Intervention Clinical Trial

NCT06388109

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • Northeast Valley Health Corporation Van Nuys, California, United States
  • Infectious Disease Practice- Rutgers University Newark, New Jersey, United States
  • Equitas Health Cincinnati, Ohio, United States
  • Equitas Health Columbus, Ohio, United States
View Trial Details
Recruiting

Screen2Prevent (S2P)

NCT07728123

Conditions
Blood-Borne Infections, Communicable Diseases, Disease Attributes, +15 more
Locations
  • University of South Florida Tampa, Florida, United States
  • Emory Atlanta Adolescent Consortium Atlanta, Georgia, United States
  • Johns Hopkins University Baltimore, Maryland, United States
  • St. Jude Children's Research Hospital Memphis, Tennessee, United States
View Trial Details
Recruiting

A Continued Access Study for Participants Transitioning From ViiV Healthcare-sponsored or ViiV Healthcare-collaborative Parent Studies for HIV Treatment

NCT07393659

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +13 more
Locations
  • GSK Investigational Site Durban, KwaZulu-Natal, South Africa
  • GSK Investigational Site Jouberton, Matlosana, South Africa
  • GSK Investigational Site Gauteng, South Africa
  • GSK Investigational Site Johannesburg, South Africa
View Trial Details
Recruiting

A Study to Investigate Cabotegravir Ultra Long-Acting (CAB ULA) Plus Rilpivirine Ultra Long-Acting (RPV ULA) in Adults and Adolescents With HIV Who Are Virologically Suppressed

NCT07650916

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • GSK Investigational Site Phoenix, Arizona, United States
  • GSK Investigational Site Bakersfield, California, United States
  • GSK Investigational Site Los Angeles, California, United States
  • GSK Investigational Site Los Angeles, California, United States
View all 88 locations
View Trial Details
Recruiting

Study of Lenacapavir, Teropavimab, and Zinlirvimab Versus Cabotegravir and Rilpivirine in Virologically Suppressed Adults With HIV-1 on Oral Daily Antiretroviral Therapy

NCT07682961

Conditions
Blood-Borne Infections, Communicable Diseases, Genital Diseases, +11 more
Locations
  • CAN Community Health Fort Lauderdale Fort Lauderdale, Florida, United States
  • Midway Immunology and Research Center Ft. Pierce, Florida, United States
  • Be Well Medical Center Berkley, Michigan, United States
  • Optimus Medical Group San Francisco, California, United States
View all 19 locations
View Trial Details

Related conditions